Sutro Biopharma Other Long Term Liabilities (Quarterly) Analysis

Sutro Biopharma, Inc. (STRO)

12.64 +2.01 (+18.91%) USD | NASDAQ | Jan 14, 16:00

12.64 0.00 (0.00%) After-Hours: 19:36

View Other Long Term Liabilities (Quarterly) for STRO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

GT Biopharma, Inc.	--
Daré Bioscience, Inc.	Upgrade
Syndax Pharmaceuticals, Inc.	Upgrade
Crinetics Pharmaceuticals, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	--